Ads
related to: what is diabetes mellitus- Learn About T1D Treatment
Discover T1D Treatment for
Appropriate Patients
- Familial Risk
Discover T1D Familial Risks
For Patients
- Patient Criteria
Learn How Patients Qualify
For This T1D Treatment
- How To Screen For T1D
Learn How To Screen
Patients For T1D
- Learn About T1D Treatment
Search results
Acrochordons may be marker for metabolic disease in children
Medical Xpress· 7 days agoIn pediatric patients, acrochordons may be a marker for metabolic disease, according to a study...
Health Care Week in Review: Senate Finance Committee Releases Plan to Address Workforce Shortages,...
JD Supra· 1 day agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
Popular Japanese tea protects your gums and teeth: Scientists
Newsweek· 7 days agoYour favorite green latte might help keep your mouth healthy, researchers have found. Matcha—a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoGlobal Immunoassay Market to Witness Growth at a CAGR of ~8% by 2030 | DelveInsight PR Newswire LAS VEGAS, May 27, 2024 The surge in the immunoassay market is mainly from the rising occurrence ...
Matcha: Nature’s Answer to Fighting Gum Disease
SciTechDaily· 5 days agoClinical trials confirm matcha’s effectiveness in reducing Porphyromonas gingivalis levels in patients with periodontitis, highlighting its potential in...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 21 hours agoLA JOLLA, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that
Teacher Retirement System of Texas Sells 4,394 Shares of Corcept Therapeutics Incorporated...
ETF DAILY NEWS· 4 days agoTeacher Retirement System of Texas lowered its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 17.9% during the 4th quarter, according to the company in its most recent ...
Structure Therapeutics (NASDAQ:GPCR) Shares Up 3.4%
ETF DAILY NEWS· 5 days agoStructure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) shares rose 3.4% during mid-day trading on Wednesday . The company traded as high as $38.75 and last traded at $37.04. Approximately ...
Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $35.78
ETF DAILY NEWS· 6 days agoStructure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $35.78, but opened at $37.48. Structure Therapeutics ...
Ads
related to: what is diabetes mellitus
